Immunotherapy plus targeted therapy for recurrent or metastatic head and neck squamous cell carcinoma: an updated meta-analysis and subgroup analysis by target mechanism
{{output}}
Background: Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy with dismal outcomes for patients with recurrent or metastatic (R/M) disease. Although immune checkpoint inhibitors (ICIs) have reshaped the tr... ...